Physician
Wheatfield Pediatrics, LLP
Wheatfield Pediatrics, LLP was paid $2.60M by Medicaid between Jan 2018 and Nov 2024, across 67 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 44% of everything it billed.
33Billing provider infoWHEATFIELD PEDIATRICS, LLP
NORTH TONAWANDA, NY 14120
NORTH TONAWANDA, NY 14120
33aNPI1699753053assigned 01/05/2006
33bProvider typePediatrics Physician
28Total paid$2.60M
24GClaims100,089
24DCodes billed67
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#131 of 1,983
Median peer was paid$17K
This provider vs. median153×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,307 | $157K | |
| 2019 | 9,065 | $238K | |
| 2020 | 14,564 | $324K | |
| 2021 | 28,052 | $534K | |
| 2022 | 15,465 | $461K | |
| 2023 | 16,174 | $497K | |
| 2024incomplete | 11,462 | $393K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 44% | 23,748 | 22,965 | $1.15M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.9% | 3,427 | 3,427 | $232K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 8.8% | 17,680 | 17,606 | $230K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.3% | 2,930 | 2,837 | $216K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.1% | 2,763 | 2,763 | $184K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 5.8% | 2,115 | 1,774 | $152K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.4% | 1,445 | 1,438 | $89K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.4% | 1,199 | 1,199 | $88K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 2.7% | 623 | 623 | $69K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.0% | 1,194 | 1,186 | $53K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 1.9% | 1,190 | 1,066 | $49K |
| 87428 | <1% | 374 | 372 | $16K |
55 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 370 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,405 | $9K |
| 96127 | <1% | 1,609 | $9K | |
| 0002A | <1% | 240 | $7K | |
| 0072A | <1% | 217 | $6K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 373 | $6K |
| 0071A | <1% | 183 | $5K | |
| 0001A | <1% | 175 | $5K | |
| 90686 | <1% | 5,440 | $3K | |
| 99177 | <1% | 7,954 | $2K | |
| 90656 | <1% | 483 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 495 | $2K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 101 | $1K |
| 0003A | <1% | 35 | $1K | |
| 0124A | <1% | 30 | $873.50 | |
| 87807 | <1% | 57 | $788.70 | |
| 0011A | <1% | 27 | $679.06 | |
| 0012A | <1% | 22 | $655.89 | |
| 0112A | <1% | 20 | $551.86 | |
| 90685 | <1% | 38 | $518.78 | |
| 90480 | <1% | 19 | $410.00 | |
| 90670 | <1% | 571 | $394.85 | |
| 0111A | <1% | 13 | $363.28 | |
| D1206 | Topical application of fluoride varnish | <1% | 12 | $360.00 |
| 83655 | <1% | 25 | $327.76 | |
| 90698 | <1% | 521 | $160.00 | |
| 99173 | <1% | 2,367 | $150.73 | |
| 99421 | <1% | 14 | $123.34 | |
| 94760 | <1% | 1,432 | $118.96 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13 | $116.07 |
| 99188 | <1% | 12 | $115.95 | |
| 99051 | <1% | 46 | $105.14 | |
| 96161 | <1% | 90 | $102.40 | |
| 99441 | <1% | 12 | $77.39 | |
| 85018 | <1% | 27 | $50.00 | |
| 92551 | <1% | 12 | $45.08 | |
| 90680 | <1% | 157 | $40.00 | |
| 96160 | <1% | 13 | $5.78 | |
| 99072 | <1% | 13,921 | $0.87 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 13 | $0.43 |
| 91311 | 0% | 46 | $0.00 | |
| 90671 | 0% | 195 | $0.00 | |
| 91300 | 0% | 478 | $0.00 | |
| 91312 | 0% | 16 | $0.00 | |
| 90734 | 0% | 28 | $0.00 | |
| 99080 | 0% | 28 | $0.00 | |
| 90710 | 0% | 14 | $0.00 | |
| 91321 | 0% | 14 | $0.00 | |
| 99000 | 0% | 366 | $0.00 | |
| 91307 | 0% | 486 | $0.00 | |
| 36416 | 0% | 52 | $0.00 | |
| 91301 | 0% | 54 | $0.00 | |
| 91305 | 0% | 34 | $0.00 | |
| 90651 | 0% | 13 | $0.00 | |
| 90744 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEVANTIER, SARA (OFFICE MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Pediatric Now Medical Care, PLLC | Liverpool, NY | $36K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.